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Cytokines possess discrepant effects on tumour cells varying from anti- to proapoptotic activities. We recently reported that
testicular germ cell tumours (TGCT) express a functional form of the proinflammatory cytokine interferon-gamma (IFNg). The
present study asked whether TGCT-derived IFNg influences survival or death of neoplastic germ cells. Analysis of TGCT cell lines
demonstrated that they expressed and secreted IFNg, but were resistant to the endogenous IFNg since neutralisation of IFNg by a
specific blocking antibody had no influence on the proliferation and/or the degree of apoptosis of tumour cells. To study mechanisms
providing tumour resistance to endogenous IFNg, we analysed primary TGCT and two human TGCT cell lines (NTERA and NCCIT)
for the expression of IFNg receptor and for the level of phosphorylation of the signal transducer and activator of transcription
(STAT)-1. In situ hybridisation, immunocytochemistry, Western blot analysis and flow cytometry indicated that primary TGCT as well
as NCCIT and NTERA cell lines expressed the heterodimeric cell surface IFNg receptor which consists of both 90-kDa a- and the
85-kDa b-chains. However, the downstream transcription factor STAT-1 was not phosphorylated constitutively, indicating that
STAT-1 is not activated by the endogenous IFNg. Upon application of recombinant human IFNg in excess, however, STAT-1 was
phosphorylated and the interferon regulatory factor-1 (IRF-1) was induced, suggesting that both IFNgR and STAT-1 are functionally
intact in TGCT. Altogether our results suggest that despite secreting biologically active IFNg, the concentration of the endogenous
IFNg is too low to stimulate the IFNgR/STAT signalling pathway in TGCT in an autocrine and/or paracrine manner.
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Interferon-g (IFNg) is a pleiotropic cytokine mainly secreted by
activated T lymphocytes and natural killer (NK) cells (Mosman
and Sad, 1996). The cellular response to IFNg is mediated by a
heterodimeric cell surface receptor (IFNgR), which consists of two
subunits, the 90-kDa a chain (IFNgRa) and the 85-kDa b chain
(IFNgRb) (Valente et al, 1992; Pestka et al, 1997). Ligation of IFNg
to the a chain clusters the neighbouring b chain of the IFNgR
followed by Janus kinase-mediated phosphorylation of the signal
transducer and activator of transcription (STAT)-1, the homo-
dimer of which migrates to the nucleus and stimulates gene
transcription such as the interferon regulatory factor-1 (IRF-1)
(Haque and Williams, 1998; Wagner et al, 2002).
After the first report of its ability to protect cells from viral
infection, IFNg has been demonstrated to play a crucial role in host
defence, inflammation and autoimmunity. For instance, IFNg has
been shown to augment antigen presentation by upregulation of
major histocompatibility complex class I and II molecules, to
induce proinflammatory cytokines in effector cells and to
orchestrate leukocyte–endothelium interaction by upregulation
of adhesion molecules (Boehm et al, 1997). Regarding induction of
apoptosis, however, IFNg seems to play a paradoxical role in
different normal and neoplastic cell types. Whereas in normal
macrophages and neoplastic myeloid and NK cells, IFNg prevents
apoptosis (Lotem and Sachs, 1996; Mizuno et al, 1999; Xaus et al,
1999), it enhances apoptosis of tumour cells in malignancies such
as pancreatic carcinoma, colon carcinoma and ovarian carcinoma
(Adachi et al, 1999; Burke et al, 1999; Detjen et al, 2001).
Testicular germ cell tumours (TGCT) are the most common
solid malignancy in young males from 20 to 40 years old and
represent a heterogeneous group of different histological entities
composed of seminomatous and nonseminomatous tumours
(Ulbright, 1993) that are almost all infiltrated by various numbers
of T lymphocytes (Torres et al, 1997). In an attempt to investigate
mechanisms navigating T lymphocytes into the TGCT, we
observed that neoplastic germ cells express IFNg (Schweyer et al,
2002). Based on this evidence and considering the dual role of IFNg
in apoptosis of neoplastic cells, we asked whether TGCT-derived
IFNg possesses any effect on survival or death of TGCT.
MATERIALS AND METHODS
Tissue samples
Tumour specimens were obtained from 12 patients who underwent
orchiectomy for testicular tumour. Patients had not received any
chemotherapeutic or immunomodulatory treatment before opera-
tion. The mean age at the time of operation was 36.8 years, ranging Received 13 March 2003; revised 16 May 2003; accepted 30 June 2003
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sfrom 28 to 55 years. Tumour tissues were classified according to
the classification system of the World Health Organization (six
cases of pure seminoma, six cases of combined tumour containing
nonseminomatous and seminomatous components) (Mostofi,
1980). Probes from normal testes were obtained from three
patients who underwent bilateral orchiectomy because of prostatic
cancer. Two blocks of each testis were immediately frozen in liquid
nitrogen and stored at  801C until analysed by reverse transcrip-
tion–polymerase chain reaction (RT–PCR). Samples of each tissue
specimen were also fixed in neutral formalin and processed for
histology, immunohistochemistry and in situ hybridisation (ISH).
Testicular germ cell tumour cell lines
The human TGCT cell lines used in this study were NTERA
(American Type Culture Collection, ATCC, Manassas, VA, USA;
CRL-1973) and NCCIT (ATCC, CRL-2073). The cell lines were
grown as monolayers and maintained in HEPES-buffered RPMI
1640 (Biochrom, Berlin, Germany) supplemented with 10% fetal
calf serum (FCS) (CC Pro, Neustadt, Germany), 100IUml
 1
penicillin (Sigma, Deisenhofen, Germany), 100mgml
 1 streptomy-
cin (Sigma) and 2mML -glutamine (Life Technologies, Karlsruhe,
Germany). Cultures were incubated at 371C in a humid atmosphere
with 5% carbon dioxide in air.
Human monocytes
Blood monocytes were obtained from healthy volunteers as
described previously (Schweyer et al, 2002). A total of 2.5 10
5
monocytes were cultured in basis medium containing RPMI 1640,
2m ML -glutamine, 1% penicillin and streptomycin, and 15%
human serum for 1 day. The cells were then stimulated for 12h
by recombinant human IFNg (rhIFNg; R&D Systems) at a final
concentration of 200Uml
 1 before being analysed for the
expression of IFNgRa and IFNgRb and for the phosphorylation
of STAT-1 (see below).
Human umbilical vein endothelial cells
Human umbilical vein endothelial cells (HUVEC) were isolated
and cultured as described previously (Schweyer et al, 2002). The
cells were then stimulated for 9h by rhIFNg (1000Uml
 1) and
rhTNFa (100Uml
 1) before being studied for the expression of
IRF-1 as described elsewhere (Wagner et al, 2002).
Proliferation and apoptosis of TGCT cell lines following
IFNc neutralisation
NCCIT and NTERA cells (1 10
6) were cultured in 96-well round-
bottom microtitre plates (Nunc, Wiesbaden, Germany) at 371Ci n
5% CO2 atmosphere in the presence of a specific neutralising
polyclonal antibody against human IFNg (R&D Systems, Heidel-
berg, Germany) in excess (100, 500 or 1000mgml
 1) or in the
presence of control isotype-matched IgG (100, 500 or 1000mgml
 1,
Dako, Hamburg, Germany) for 24 or 48h.
To assess the proliferation activity of NCCIT and NTERA cells,
plates were pulsed with 1mCi per well of [
3H]thymidine. After 24 or
48h, the cells were collected by an automated Inotech cell
harvester (Dunn, Ansbach, Germany) and the radioactivity was
measured with a b-counter (Hewlett-Packard, Meriden, CT, USA).
Results were expressed as counts per minute (c.p.m.)7s.e.m. Each
experiment was performed in triplicate and was repeated three
times.
To determine the apoptotic rate of NCCIT and NTERA cells,
they were harvested at 24 or 48h after application of neutralising
antibody or control IgG. Then the cells underwent May–Giemsa–
Grunwald (MGG) staining, or immunocytochemistry for the active
form of caspase-3, or in situ end labelling (ISEL) for DNA
fragmentation. For control, NCCIT cells were incubated with 50mM
cisplatin (Holzkirchen, Germany) for 24h and proved to be
apoptotic as described previously (Burger et al, 1999). Each
experiment was performed in triplicate and was repeated three
times.
May–Giemsa–Grunwald staining
Centrifuged cells (2 10
3) were dried for 24h, fixed in 100%
acetone for 10min, stained with MGG and embedded in ‘Super-
Mount Medium’. Apoptotic cells were identified by cellular
shrinkage and nuclear condensation and fragmentation.
Immune staining
Antibodies The monoclonal antibody against placental-like alka-
line phosphatase (PLAP, clone 8A9) and the monoclonal antibody
against cytokeratine (clone MNF116) were obtained from Dako
(Hamburg, Germany); the monoclonal antibody against IFNgRa
(clone GIR-94), the polyclonal antibody against IFNgRb (C-20) and
the polyclonal antibody against pStat-1 (Tyr701) were from Santa
Cruz Biotechnology (Heidelberg, Germany); and the polyclonal
antibody against IFNg (AF-285-NA) and the polyclonal antibody
recognising the active form of caspase-3 were from R&D systems
(Wiesbaden, Germany). The antibodies were applied at a working
dilution of 1:25 (IFNg) or 1:50 (PLAP, cytokeratine, IFNgRa,
IFNgRb, pSTAT-1 and active caspase-3).
Immunohistochemistry Immunohistochemical reactions for IFN-
gRa and IFNgRb were performed on frozen sections. After
incubation with the primary antibody, the sections were incubated
with a horseradish peroxidase (HRP)-conjugated biotin–strepta-
vidin amplified system (Dako) and the signals were visualised with
3,30-diaminobenzidine (DAB; Dako) as described previously
(Fayyazi et al, 2000). Immunohistochemical reactions for PLAP
and cytokeratin were performed on paraffin-embedded serial
sections. After incubation with the primary antibody, the sections
were incubated with an AP-conjugated or an HRP-conjugated
biotin–streptavidin amplified system (Dako) and the signals were
visualised with fast red or AEC (Dako) as described elsewhere
(Schweyer et al, 2000). All samples were counterstained with
Meyer’s haematoxylin, mounted in Super Mount Medium and
analysed by light microscopy. Controls were stained as above
omitting primary or secondary antibodies.
Immunofluorescence and immunocytochemistry Fresh tumour
tissue was mechanically dissociated in a suitable volume of RPMI
1640 supplemented with 100IUml
 1 penicillin, 100mgl
 1 strep-
tomycin and 2mML -glutamine. Cells were spun down at 1500 r.p.
m. for 5min and the pellet was resuspended in 500ml ice-cold
phosphate-buffered saline (PBS). Then, 5 10
5 cells were cytocen-
trifugated on slides coated with 2% 3-aminopropyltriethoxy-silane,
dried for 24h and fixed with 100% acetone for 10min at room
temperature. For immunocytochemical staining, cells were in-
cubated for 30min with a primary antibody against IFNg, IFNgRa,
IFNgRb, active form of caspase-3 or p-STAT-1. To visualise bound
primary anti-IFNg-antibody, cells were incubated with an FITC-
labelled rabbit anti-goat IgG (working dilution 1:500) for 1h
(Dako), mounted with ‘Fluorescent Mounting Medium’
s and
examined using fluorescence microscopy. To visualise bound
primary anti-IFNgRa, anti-IFNgRb, anti-active caspase-3 and p-
STAT-1 antibodies, cells were incubated with AP-conjugated or
HRP-conjugated biotin–streptavidin amplified system (Dako) as
described previously (Schweyer et al, 2000). Fast red or AEC
(Dako) was applied as chromogen. After signal development, cells
were counterstained with Meyer’s haematoxylin, mounted in Super
Mount Medium and analysed by light microscopy. IFNg-stimu-
lated human monocytes served as positive control.
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sIn situ end labelling (ISEL)
Fixed centrifuged cells (2 10
3) were incubated with TBS (50mM
Tris-HCl; 150mM NaCl; pH 7.5) containing 10% FCS and 0.3%
H2O2 for 15min. The cells were then incubated for 60min at 371C
with 50ml of the labelling mix (250Uml
 1 terminal transferase,
20mlml
 1 Digoxigen-DNA labelling mix at 10  concentration and
1mmoll
 1 CoCl2 in reaction buffer for terminal transferase
(Roche, Mannheim, Germany)). After rinsing in TBS, the cells
were blocked with 10% FCS and incubated for further 60min
with a rabbit HRP-conjugated F(ab)2 fragment against
digoxigenin (working dilution: 1:500, Dako). 3,30-Diaminobenzi-
dine was next applied as chromogen. Cells with fragmented
DNA revealed nuclear brown signals. DNA-fragmented cells
with intact plasma membrane were considered to be apoptotic.
Negative controls were stained as above but without terminal
transferase.
Identification and quantification of apoptosis and
statistical analysis
Apoptotic cells were identified by nuclear condensation and
fragmentation in MGG staining, by positive cytoplasmic signals
for the active form of caspase-3 in immunocytochemistry or
by DNA fragmentation in ISEL. All experiments were per-
formed in triplicate and were repeated three times with similar
results.
Percentage of apoptotic cells was calculated as the ratio of
apoptotic cells to 500 cells counted. Results are expressed as the
mean 7s.e.m. The differences were analysed with a t-test and were
considered significant at Po0.05.
RNA extraction and RT–PCR
Total RNAs were extracted from TGCT cell lines as well as from
IFNg-stimulated human monocytes using the Qiagen RNA
isolation kit (Qiagen, Hilden, Germany), digested with DNAse I
and transcribed to cDNA using oligo-d(T) primers and SuperScript
II reverse transcriptase (RT) (Life Technologies). In brief, 1–5mg
of total cellular RNA was incubated for 50min at 371C with 50U of
RT and 20U placental RNase Inhibitor in a 20-ml volume
containing 2.5mmoll
 1 oligo-d(T) primers, 5mmoll
 1 MgCl2,
50mmoll
 1 KCl, 10mmoll
 1 Tris-HCl and 1mmoll
 1 of each of
the deoxynucleoside-triphosphate, heated to 701C and subse-
quently cooled to 51C.
The quantity and quality of the extracted RNA were determined
by spectrophotometry and agarose gel electrophoresis. Polymerase
chain reaction amplification of b-actin cDNA was performed on
each sample as a control for efficient cDNA synthesis. Negative
controls, which were performed without cDNA adjunction in the
reagent mixture, were included for every PCR analysis. Specific
primers were custom synthesised (MWG, Ebersberg, Germany)
and specific fragments were amplified using primer pairs as
follows: IFNg,5 0-GATGACCAGAGCATCCAAAAGAG-30,5 0-GCAT-
CTGACTCCTTTTTCGCTTC-30; IFNgRa,5 0-CCGAAGACAATC-
CAGGAAAA-30,5 0-GGAGGTGGGGGCTTTTATTA-30; IFNgRb,
50-GGAGGAATCCAACAGGTCAA-30,5 0-CAGACGTCATCCTTTG-
GTGA-30. The PCR reaction mixture consisted of 1.5mmoll
 1
MgCl2, 50mmoll
 1 KCl, 10mmoll
 1 Tris-HCl, 0.2mmoll
 1 each of
both the primers and 2.5U of Taq DNA polymerase (Pharmacia,
Freiburg, Germany) in a 0.1ml volume containing 20ml of the
above-mentioned RT reaction mixture. Reaction conditions were:
2min at 961C followed by 35 cycles of 30s at 951C, 45s at specific
annealing temperature (IFNg 561C, IFNgRa 581C, IFNgRb 581C)
and 45s at 721C, and a final extension at 721C for 10min. The
amplified products were electrophoresed in ethidium bromide-
stained 1.5% agarose gel.
Subcloning of IFNc, IFNcRa and IFNcRb cDNA,
preparation of cRNA probes and nonradioactive ISH
For preparation of riboprobes, fragments of the human IFNg,
IFNgRa and IFNgRb cDNA were subcloned into pBluescript II
KSþ phagemid (Stratagene, CA, USA). The subcloned fragment
served as template for in vitro transcription of digoxigenin-11-
dUTP labelled antisense and sense probes, which were generated
by virtue of T3- and T7-polymerase according to the manufac-
turer’s instructions (Roche).
In situ hybridisation for IFNg mRNA was performed according
to the method described previously (Schweyer et al, 2002). After
signal detection, specimens were subjected to double-staining by
indirect immunofluorescence for TGCT markers PLAP and
cytokeratin, as described above (Schweyer et al, 2002). To detect
and visualise IFNgR transcripts, the Catalyzed Signal Amplification
System was used as recommended by the manufacturer (Dako).
DAB (Dako) was applied as chromogen. After signal detection,
specimens were mounted in Super Mount Medium. For each tissue
specimen, sense riboprobes were applied as controls and proved to
be negative.
Flow cytometry
NCCIT-, NTERA- and IFNg-stimulated human monocytes were
spun down at 1500r.p. m. for 5min and the pellet was resuspended
and washed in 500ml of ice-cold TBS. The cell suspension was then
centrifuged again at 1500r.p.m. and resuspended in 10ml RPMI
1640 cell culture medium. Cells were then transferred to 96-well
round-bottom microtitre plates (Nunc, Wiesbaden, Germany),
which had been precoated by blocking buffer (10% heat-
inactivated rabbit serum and 0.1% NaN3 in PBS). Thereafter, they
were incubated for 30min with a monoclonal antibody against
human IFNgRa, a polyclonal antibody against IFNgRb or irrelevant
mouse/rabbit IgG (Dako). After washing with PBS, the cells were
incubated for further 30min with an FITC-conjugated goat anti-
mouse or a PE-conjugated goat anti-rabbit antibody (Dako). Cells
were then washed again, fixed with 2% paraformaldehyde and
subjected to flow cytometric analysis using FACStar
plus (Becton
Dickinson, San Jose, CA, USA).
Western blot
For immunoblot analysis, TGCT cell lines were harvested in 500ml
of lysis buffer (0.4% sodium deoxycholate, 1% NP-40, 50mM
EGTA, pH 7.4, 10mM Tris pH 7.4, 1mM phenylsulphonyl fluoride
(PMSF), 10mgml
 1 leupeptin, 10mgml
 1 aprotinin). The resulting
lysates were resolved on 10% sodium dodecyl sulphate–poly-
acrylamide gel electrophoresis (SDS–PAGE) gels and transferred
onto nitrocellulose membranes (Schuett, Go ¨ttingen, Germany) or
polyvinylidene fluoride transfer membrane (Pall Corporation,
Rodorf, Germany). The membranes were blocked with Tris-
buffered saline with Tween 20 (10m Tris-HCl, pH 7.4, 150mM
NaCl, 0.1% Tween 20) containing 5% milk and then incubated with
the antibodies against IFNgRa, IFNgRb, pSTAT-1 or IRF-1 (Santa
Cruz). The working dilution of antibodies used for Western blots
was 1:2000. Proteins were detected using enhanced chemilumi-
nescence (ECL) reagents (Amersham Pharmacia Biotech, Freiburg,
Germany). Loading and transfer of equal amounts of protein in
each line was verified by reprobing the membrane with a
monoclonal anti-b-actin antibody (Sigma). Lysates of IFN-
stimulated HeLa cells (Santa Cruz) served as positive control.
ELISA
Extracellular IFNg level in culture supernatants of TGCT cell lines
was measured via commercial ELISA (R&D) as recommended by
the manufacturer. The lower limit for assay was IFNg o3pg.
Resistance of TGCT to endogenous IFNc
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Testicular germ cell tumours express IFNc
To determine the expression and cellular localisation of IFNg in
TGCT, in situ analyses were performed. Whereas no IFNg
expression was noted within the normal testes (data not shown),
nonradioactive ISH revealed that numerous tumour-infiltrating
mononuclear cells and almost all neoplastic germ cells indepen-
dent of their histological type expressed IFNg mRNA (Figure 1).
Consequently, we asked whether IFNg mRNA is translated into
IFNg protein. To answer this question, tumour cells were isolated
from TGCT and subjected to immunofluorescence. Results
demonstrated that primary TGCT not only produce IFNg mRNA
but also IFNg protein (Figure 1).
For an autocrine effect, IFNg must be secreted by tumour cells.
To prove this, we analysed two well-established human TGCT cell
lines NCCIT and NTERA, for the expression and secretion of IFNg.
Reverse transcription–polymerase chain reaction RT–PCR
showed that both cell lines expressed IFNg mRNA (data not
shown). Applying ELISA, significant amounts of secreted IFNg
(343–112pgml
 1) were found in culture supernatants of NCCIT
and NTERA, as described previously (Schweyer et al, 2002) (data
not shown). Based on this background, we next asked whether
TGCT-derived IFNg influences the proliferation and/or apoptosis
of the testicular tumour cells in an autocrine manner.
Testicular germ cell tumour-derived IFNc does not affect
proliferation or apoptosis of TGCT cell lines
To study the effect of the secretory IFNg on multiplication and/or
death of TGCT cells, endogenous IFNg was blocked by adding
different concentrations of a neutralising antibody to the cultured
NCCIT and NTERA cells for 24 or 48h. Results from the
[
3H]thymidine assay demonstrated that IFNg has no effect on
proliferation of the TGCT cell lines when compared to controls. In
accordance, immunocytochemistry for the active form of caspase-
3, ISEL for DNA fragmentation and MGG staining for the detection
of nuclear condensation and fragmentation showed that although
the apoptosis rate of tumour cells was increased following IFNg
neutralisation when compared to controls, the differences among
the groups remain, however, not significant (P40.05). Figure 2
demonstrates results from proliferation and apoptosis assays on
TGCT cell lines 24h after IFNg neutralisation. Similar results were
also seen 48h after beginning IFNg neutralisation (data not
shown).
Testicular germ cell tumours express both IFNcR subunits
a and b
Since it is known that IFNg mediates its effects by binding to a
specific high-affinity receptor (Boehm et al, 1997), we asked
whether the unresponsiveness of TGCT to the endogenous IFNg is
due to the lack or dysfunction of IFNgR on neoplastic germ cells.
Nonradioactive ISH revealed that in addition to numerous
tumour-infiltrating mononuclear cells, almost all tumour cells
independent of their histological type expressed IFNgRa and
IFNgRbmRNAs (Figure3).Consequently, theexpression ofIFNgRa
and IFNgRb proteins in primary tumours was examined by
immunohistochemistry and immunocytochemistry. Results illu-
strated both IFNgR subunits on neoplastic germ cells in primary
TGCT as well as on the surface membrane of tumour-infiltrating
mononuclear cells (Figure 3). Within the normal testes, however,
no expression of IFNgRa or IFNgRb was noted in germ cells
(Figure 3). In situ hybridisation and immunohistochemistry,
however, indicated that IFNgRb, but not IFNgRa, was expressed
in Leydig cells (Figure 3). In addition to primary tumours, both
human TGCT cell lines were also examined for the IFNgR
expression. RT–PCR, Western blot and FACS analyses demon-
strated that NCCIT and NTERA cell lines express IFNgRa and
IFNgRb (Figure 4).
Testicular germ cell tumours lack STAT-1 activation
After demonstration of the IFNgR expression on TGCT, the
functional activity of the IFNgR was analysed. For this, we
examined whether the transcription factor STAT-1 is phosphory-
lated in IFNg-expressing neoplastic germ cells because it is known
that a sufficient stimulation of IFNgR results in a STAT-1
activation through phosphorylation. Immunocytochemistry on
tumour cells isolated from primary TGCT and Western blot
analysis of NCCIT and NTERA cell lines revealed that STAT-1 is
not constitutively phosphorylated in neoplastic germ cells
(Figure 5). To examine whether the IFNgR/STAT signaling
pathway is intact in TGCT cells, we stimulated NCCIT and NTERA
cell lines with different doses of rhIFNg. Western blot analysis
demonstrated that upon stimulation STAT-1 was phosphorylated
and IRF-1 was induced in both cell lines (Figure 5), suggesting that
both IFNgR and STAT-1 are biologically intact.
Figure 1 Expression of IFNg in primary TGCT (A–C). Nonradioactive
ISH reveals IFNg transcripts in a representative TGCT with seminomatous
differentiation (A, black signals). Combination of ISH with immunofluor-
escence shows that IFNgþ cells are neoplastic germ cells expressing the
seminoma marker PLAP (B, green signals). Immunocytochemistry illustrates
the expression of IFNg protein in isolated neoplastic germ cells of the same
tumour (C, green signals).
Resistance of TGCT to endogenous IFNc
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sDISCUSSION
In the present study, we investigated the effect of IFNg on
proliferation and apoptosis of TGCT. Analyses showed IFNg in
almost all neoplastic germ cells of primary TGCT. The data
presented in this report extended our previous findings (Schweyer
et al, 2002) because they demonstrated that primary TGCT not
only expressed IFNg mRNA but also IFNg protein. These findings
were surprising, because IFNg is normally expressed and secreted
by inflammatory leucocytes (Elgert et al, 1998) but not by tumour
cells. Moreover, IFNg is primarily known as a cytokine with several
antitumour properties. For instance, it has been shown that IFNg
possesses direct cytotoxic effects on ovarian carcinoma cell lines
(Kim et al, 2002), augments apoptosis-inducing capacity of TNFa
in cervical carcinoma cells (Suk et al, 2001), reduces the
proliferation activity of colon carcinoma cells and melanoma cells
(Raitano and Korc, 1993; Krasagakis et al, 1995), and is able to
upregulate MHC molecules on renal cell carcinomas, thus leading
to a better recognition of neoplastic cells by cytotoxic T cells
(Totpal and Aggarwal, 1991; Hillman et al, 1997). In addition to
these antitumour activities, however, IFNg seems to have also some
powerful protumour effects. For instance, it is well known that
IFNg is a potent inhibitor of apoptosis in some haematological
malignancies (Lotem and Sachs, 1996; Mizuno et al, 1999).
Based on this background, we hypothesised that endogenous
IFNg affects the proliferation and/or apoptosis of neoplastic germ
cells. To prove this hypothesis, we first analysed two human TGCT
cell lines for the expression and secretion of IFNg. Results
demonstrated that both NCCIT and NTERA cell lines produce
and release significant amounts of IFNg. Next, we neutralised the
IFNg in culture supernatants of the TGCT cell lines by applying a
specific antibody to study the role of secretory IFNg on the
neoplastic germ cells. Using independent proliferation and
apoptosis assays, we did not however note any evidence showing
that the endogenous IFNg influences the multiplication and/or the
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Figure 2 Proliferation and apoptosis of two TGCT cell lines (A and B).
NCCIT and NTERA cells were incubated with different concentrations of a
neutralising antibody (Ab) against human IFNg (100, 500 or 1000mgml
 1)
or with control isotype-matched IgG (100, 500 or 1000mgml
 1). After
24h, the proliferation activity and the apoptosis rate of the cells were
assessed by [
3H]thymidine assay and morphological methods, respectively.
The [
3H]thymidine assay does not reveal any significant difference in the
proliferation activity of NCCIT or NTERA cells following IFNg neutralisa-
tion (white columns) when compared with controls (black columns).
Results are expressed as counts per minute (c.p.m.)7s.e.m. (A). To prove
the effect of IFNg neutralisation on apoptosis of NCCIT and NTERA cells,
they were stained with MGG for the detection of nuclear condensation and
fragmentation, with immunocytochemistry for the active form of caspase-3
and with ISEL for DNA fragmentation. Representative photomicrographs of
active caspase-3 (black cytoplasmic signals) and of DNA fragmentation
(black nuclear signals) illustrate no significant difference in apoptosis rate of
cells incubated with the anti-IFNg Ab (1000mgml
 1) or incubated with
control IgG (1000mgml
 1)( B). The diagrams show quantification of
tumour cell apoptosis with MGG staining following application of anti-IFNg
Ab (white columns) or control IgG (black columns) (B). Each experiment
was performed in triplicate and was repeated three times. The values given
(*P40.05, Student’s t-test) are for the statistical significance of the
difference between the two groups.
Figure 3 Expression of IFNgR in primary TGCT and normal testis (A–
H). Nonradioactive ISH demonstrates IFNgRa mRNA (A and C, brown
signals) and IFNgRb mRNA (B and D, brown signals) in a representative
TGCT with seminomatous differentiation (A and B) and in a representa-
tive normal testis (C and D). Immunostaining shows the expression of
IFNgRa (E and G, brown signals) and IFNgRb proteins (F and H, brown
signals) in the same tumour (E and F) and in the same normal testis (G and
H). Note that neoplastic but not normal germ cells in tubuli seminiferi
(asterisks) express both IFNgRa and IFNgRb. Also note that, in the normal
testis, Leydig cells (arrow) express IFNgRb, but not IFNgRa.
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sdeath rate of TGCT cells. These findings, however, must be
strengthened by in vitro experiments with neoplastic cells isolated
from primary tumours.
Taking into account that the TGCT-derived IFNg is biologically
active, because it induces the c-x-c chemokine IP-10 in cultured
endothelial cells, as shown in our previous report (Schweyer et al,
2002), and considering the fact that IFNg mediates its effects
through a high-affinity receptor consisting of a ligand-binding
polypeptide chain a and a signal-transducing chain b (Pestka et al,
1997), and many tumours (e.g. hepatocellular carcinoma, prostatic
carcinoma, basal cell carcinoma) do not express both receptor
chains, thus providing tumour resistance to IFNg (Kooy et al, 1998;
Nagao et al, 2000; Royuela et al, 2000), we proved whether the
TGCT unresponsiveness to endogenous IFNg is due to the absence
of IFNgR. Applying nonradioactive ISH and immunohistochem-
istry, however, IFNgR mRNA and protein for both a and b chains
were detected in primary TGCT. Immunoblots and flow cytometry
revealed that not only primary tumours but also TGCT cell lines
express both receptor chains on their cell surface. Based on the fact
that TGCT express IFNgR and stimulation of the IFNgR results in
activation of downstream transcription factor STAT-1, we studied
the level of STAT-1 phosphorylation in neoplastic germ cells.
Analysis of primary tumours and cell lines indicated that the
transcription factor STAT-1 is not constitutively phosphorylated/
activated in TGCT. For this phenomenon, we considered three
possibilities. Firstly, the concentration of the endogenous IFNg
may be too low to stimulate the IFNgR; secondly, IFNgRi s
functionally inactive, as demonstrated in renal cell carcinomas
(Dovhey and Ghosh, 2000); and, finally, STAT-1 lacks TGCT, as
shown in pul-monary carcinoma and malignant melanoma cells
(Kaplan et al, 1998; Lee et al, 1999). Taking these possibilities into
account, we stimulated the cell lines with rhIFNg and examined
whether STAT-1 was phosphorylated and, if yes, whether pSTAT-1
acts as a functional transcription factor eliciting the expression of
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Figure 4 Expression of IFNgR proteins in TGCT cell lines (A–D).
Production of IFNgRa and IFNgRb was examined by RT–PCR (A),
Western blot (B) and FACS analysis (C). IFNgRa and IFNgRb mRNA (A)
and proteins (B and C) are expressed in both TGCT cell lines NCCIT and
NTERA. For control, human monocytes (Mo) were treated with IFNg,a s
described in Materials and Methods, and proved to express IFNgRa and
IFNgRb mRNA (A) and proteins (B and C). In part C, cells were stained by
indirect immunofluorescence with anti-IFNgRa or anti-IFNgRb antibody
(filled histograms) or with isotype control IgG (open histograms).
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Figure 5 Expression and function of STAT-1 protein in TGCT (A–E).
Production of phosphorylated STAT-1 (pSTAT-1) protein was studied in
primary TGCT as well as in TGCT cell lines. Immunocytochemistry (A and
B) and Western blot (C) demonstrate the lack of pSTAT-1 in tumour cells
from a representative TGCT with seminomatous differentiation (A) and in
NCCIT and NTERA cell lines (C). At 24h after application of rhIFNg (10,
50 or 100Uml
 1), however, STAT-1 was phosphorylated (D) and IRF-1
was induced in both TGCT cell lines (E). IFNg-stimulated monocytes (B,
red signals), commercially purchased lysates of stimulated HeLa cells (C)o r
HUVECs costimulated with rhIFNg and rhTNFa (E) served as positive
controls for immunocytochemistry and Western blots, respectively.
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sinterferon-regulated proteins such as IRF-1. Results demonstrated
that upon application of rhIFNg in excess (on an average five times
the concentration of endogenous IFNg measured in supernatants
of the TGCT cell lines), STAT-1 was phosphorylated and IRF-1 was
induced. Thus, we suggest that IFNgR and STAT-1 are biologically
intact in TGCT, but the level of the endogenous IFNg is not able to
activate the IFNgR/STAT signalling pathway in an autocrine and/
or paracrine manner. Despite the lack of direct influence on
neoplastic germ cells, an outstanding question may be whether
endogenous IFNg alters the stromal microenvironment in TGCT,
including enhancement of angiogenesis, modification of extra-
cellular matrix composition, recruitment of inflammatory cells and
dysbalance of protease activity and thereby the tumour develop-
ment and progression.
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